Evidence map›Paper›PMID 34802352›Full record

Trial reportAIDS care2022

Mediators and moderators of ART adherence effects of supporting treatment adherence readiness through training (START): evidence that START helps vulnerable clients achieve better adherence.

Glenn J Wagner, Rachana Seelam, Risa Hoffman, Bonnie Ghosh-Dastidar

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in AIDS care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Glenn J WagnerRAND Corporation, Santa Monica, CA, USA.
Rachana SeelamRAND Corporation, Santa Monica, CA, USA.
Risa HoffmanUCLA, Los Angeles, CA, USA.ORCID 0000-0001-9575-4574
Bonnie Ghosh-DastidarRAND Corporation, Santa Monica, CA, USA.
RAND Corporation · USUCLA Health · US

Funding

Controlled Evaluation of the Adherence Readiness Program for ART AdherenceR01MH104086 · NIMH · RAND CORPORATION · PI WAGNER, GLENN JOHN · 2015 to 2019
$2.8M
NIMH NIH HHS R01 MH104086
6 · The paper itself

Abstract

Supporting Treatment Adherence Readiness through Training (START) is an HIV antiretroviral adherence intervention, based on the Information Motivation and Behavioral skills (IMB) model, that significantly improved adherence in our randomized controlled trial. To understand how and for whom START had its effects on adherence, we examined mediators and moderators. Ninety-nine HIV-patients (53 control, 46 intervention) who enrolled in the trial and provided month 6 electronic monitored adherence data. The intervention was associated with increased adherence-related knowledge and lower impulsive/careless problem solving, but had no effects on other IMB-related constructs. Neither of these variables mediated the adherence effects of the intervention (based on linear regression models with bootstraping for unbiased standard errors). Four variables interacted with the intervention to moderate its effects: the intervention group had consistent high adherence across the range of depression and time since HIV diagnosis, compared to lower adherence with higher values in the usual care control; those with unstable housing or frequent drug use had higher adherence if in the intervention group compared to the control group. These findings suggest that START provides support that enables its recipients to cope with and overcome challenges (e.g., depression, unstable housing, drug use) that would typically impede adherence.

Indexed as

Anti-HIV AgentsHIV InfectionsSubstance-Related DisordersAnti-Retroviral AgentsHumansMedication AdherenceTreatment Adherence and ComplianceAnti-HIV AgentsAnti-Retroviral AgentsAdherenceARTHIVIMBmediatorsmoderators

Identifiers

PMID34802352
PMCPMC9123093
OpenAlexW3216348585

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.